ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

They've done it again: Lua Brewing claimed the No.1 spot for best brewpub in the country in the USA TODAY 10BEST Readers' Choice Awards. When Lua topped the list in 2025, the staff there bought their ...

OpenAI and Tesla alum Andrej Karpathy wrote that there was no more "business as usual" in software, thanks to AI. AI agents are "extremely disruptive to the default programming workflow," Karpathy ...

This Dutch manufacturer makes some of the world's most cutting-edge microchip production systems Elysse Bell is a finance and business writer for Investopedia. She writes about small business, ...

Before speaking with Professor Jae Woo Lee, I had gotten to know him through dozens of campus message board posts and professor reviews of his infamous course, Advanced Programming. According to a ...

Pret Advanced Materials, LLC, a supplier of thermoplastic resins, has announced an expansion of its operations in Florence County, SC. The $18.5M investment will enhance the company's capabilities and ...

What if you could strip away the layers of abstraction that operating systems impose and interact directly with your computer’s hardware? Imagine crafting a program where every instruction is executed ...

The critical vulnerability allows attacks to escape the in-memory data store’s Lua sandbox and subsequently execute arbitrary code on the underlying server. The popular Redis in-memory data store ...

Novocure (NASDAQ: NVCR) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) approved Optune Lua ® for concurrent use with PD-1/PD-L1 inhibitors for the treatment of adult ...

Optune Lua is now approved for use concurrently with PD-1/PD-L1 inhibitors in adult patients with unresectable advanced/recurrent NSCLC who progressed on or after platinum-based chemotherapy Ministry ...